XML 15 R5.htm IDEA: XBRL DOCUMENT v3.3.1.900
STATEMENTS OF CASH FLOWS - USD ($)
3 Months Ended
Nov. 30, 2015
Nov. 30, 2014
Cash flows from operating activities    
Net income $ 1,106,473 $ 528,904
Adjustments to reconcile net income to net cash provided by operating activities    
Depreciation and amortization of property and equipment 50,218 93,036
Amortization of capitalized computer software development costs 247,268 213,290
Amortization of Intellectual property 188,750 151,875
Stock-based compensation 63,962 65,799
Deferred income taxes (17,361) 32,370
(Increase) decrease in    
Accounts receivable (2,448,729) (353,283)
Revenues in excess of billings 52,186 (177,880)
Prepaid income taxes 0 122,231
Prepaid expenses and other assets 118,656 12,788
Increase (decrease) in    
Accounts payable (119,252) (36,753)
Accrued payroll and other expenses 72,355 (112,413)
Accrued bonus (90,750) (96,000)
Billings in excess of revenues 105,184 (216,715)
Accrued income taxes 341,493 0
Other liabilities (4,965) (4,965)
Deferred revenue (25,633) 4,509
Net cash provided by (used in) operating activities (360,145) 226,793
Cash flows from investing activities    
Purchases of property and equipment (1,207) (20,944)
Cash used to purchase Cognigen 0 (2,080,000)
Cash received in acquisition 0 190,184
Capitalized computer software development costs (267,300) (297,729)
Net cash provided by (used in) investing activities (268,507) (2,208,489)
Cash flows from financing activities    
Payment of dividends (849,800) (842,056)
Proceeds from the exercise of stock options 81,690 0
Net cash (used in) financing activities of continuing operations (768,110) (842,056)
Net increase (decrease) in cash and cash equivalents (1,396,762) (2,823,752)
Cash and cash equivalents, beginning of year 8,551,275 8,614,929
Cash and cash equivalents, end of period 7,154,513 5,791,177
Supplemental disclosures of cash flow information    
Interest paid 0 0
Income taxes paid 285,500 3,232
Non-Cash Investing and Financing    
Stock issued for acquisition of Cognigen Corporation 0 3,277,170
Creation of contract liability for acquisition of Cognigen Corporation $ 0 $ 1,854,404